TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy

  1. Carolina Kessler
  2. Melanie von Brandenstein
  3. Niklas Klümper
  4. Philipp Krausewitz
  5. Enno Storz
  6. Constantin Rieger
  7. Laurenz Sperber
  8. Pia Paffenholz
  9. Yuri Tolkach
  10. Ralph Wirtz
  11. Markus Eckstein
  12. Axel Heidenreich
  13. Richard Weiten
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1007/s00345-025-05880-2
  2. Version published to 10.21203/rs.3.rs-4914603/v1 on Research Square